Skip to main content
    K

    Kamada (KMDA)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $7.83
    +0.23 (+3.03%)

    Market Cap: $443.79M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    56%(22/39)
    Avg Surprise
    -5.68%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.13
    Range$0.10 - $0.16
    4 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate DriftChange to current
    90d ago$0.13+2.0%
    60d ago$0.13+2.0%
    30d ago$0.13-3.8%
    7d ago$0.13-3.8%
    Current$0.13
    Revenue Consensus
    $157M
    Range$148M - $167M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.12
    Range$0.07 - $0.17
    4 analysts
    Revenue Consensus
    $158M
    Range$150M - $166M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.12---
    Sep 26EST
    		-$0.13---
    Jun 26
    Reported Aug 12
    		$0.16$0.12+33.33%Beat+23.1%
    Mar 26
    Reported May 13
    		$0.07$0.12-41.67%Miss+0.0%
    Dec 25
    Reported Mar 11
    		$0.06$0.10-40.00%Miss-14.3%
    Sep 25
    Reported Nov 10
    		$0.09$0.09+0.00%Beat+28.6%
    Jun 25
    Reported Aug 13
    		$0.13$0.09+44.44%Beat+62.5%
    Mar 25
    Reported May 14
    		$0.07$0.07+0.00%Beat+75.0%
    Dec 24
    Reported Mar 5
    		$0.07$0.05+31.33%Beat-22.2%
    Sep 24
    Reported Nov 13
    		$0.07$0.07+0.00%Beat+16.7%
    Jun 24
    Reported Aug 14
    		$0.08$0.06+33.33%Beat+100.0%
    Mar 24
    Reported May 8
    		$0.04$0.07-42.86%Miss+200.0%
    Dec 23
    Reported Mar 6
    		$0.09$0.05+80.00%Beat+28.6%
    Sep 23
    Reported Nov 13
    		$0.06$0.02+200.00%Beat+20.0%
    Jun 23
    Reported Aug 16
    		$0.04$0.03+33.33%Beat+180.0%
    Mar 23
    Reported May 24
    		$-0.04$0.04-200.00%Miss+0.0%
    Dec 22
    Reported Mar 15
    		$0.07$0.07+0.00%Beat+163.6%
    Sep 22
    Reported Nov 22
    		$0.05$-0.03+266.67%Beat+350.0%
    Jun 22
    Reported Aug 17
    		$-0.05$-0.02-150.00%Miss-350.0%
    Mar 22
    Reported May 17
    		$-0.04$0.03-233.33%Miss-180.0%
    Dec 21
    Reported Mar 15
    		$-0.11$-0.01-1000.00%Miss-375.0%
    Sep 21
    Reported Nov 22
    		$-0.02$0.02-200.00%Miss-113.3%
    Jun 21
    Reported Aug 11
    		$0.02N/A-66.67%Miss-75.0%
    Mar 21
    Reported May 12
    		$0.05$0.07-28.57%Miss-58.3%
    Dec 20
    Reported Feb 10
    		$0.04N/A-60.00%Miss-66.7%
    Sep 20
    Reported Nov 11
    		$0.15$0.09+66.67%Beat+7.1%
    Jun 20
    Reported Aug 12
    		$0.08$0.12-33.33%Miss-46.7%
    Mar 20
    Reported May 18
    		$0.12$0.05+140.00%Beat+0.0%
    Dec 19
    Reported Feb 12
    		$0.12$0.14-14.29%Miss-73.3%
    Sep 19
    Reported Nov 13
    		$0.14$0.09+55.56%Beat+333.3%
    Jun 19
    Reported Aug 6
    		$0.15$0.17-11.76%Miss+7.1%
    Mar 19
    Reported May 14
    		$0.12$0.01+1100.00%Beat+300.0%
    Dec 18
    Reported Feb 12
    		$0.45$0.19+136.84%Beat+181.3%
    Sep 18
    Reported Nov 12
    		$-0.06$-0.02-200.00%Miss-500.0%
    Jun 18
    Reported Aug 7
    		$0.14$0.04+250.00%Beat+7.7%
    Mar 18
    Reported May 15
    		$0.03$0.04-25.00%Miss+127.3%
    Dec 17
    Reported Feb 7
    		$0.16$0.10+60.00%Beat+420.0%
    Sep 17
    Reported Nov 13
    		$-0.01$-0.01+0.00%Beat-
    Jun 17
    Reported Aug 1
    		$0.13$0.13+0.00%Beat-
    Mar 17
    Reported May 16
    		$-0.11$-0.02-450.00%Miss-
    Dec 16
    Reported Feb 6
    		$-0.05$-0.09+44.44%Beat-

    Dividends

    Dividend Metrics

    Forward Yield2.17%
    Forward Annual Dividend$0.17
    Payout Ratio67.52%
    FrequencyAnnual
    Pay MonthsApr, Sep

    Key Metrics

    Valuation
    P/E Ratio20.61EV/EBITDAN/A
    Price/FCF17.11xFCF Yield5.84%
    Profitability
    Profit Margin11.60%Operating Margin17.30%
    ROE8.41%ROICN/A
    Financial Health
    Debt/EquityN/AInterest Coverage25.72x
    Current Ratio4.06xQuick Ratio2.29x
    Trading Statistics
    Beta0.13Avg Volume100.10K
    52-Week High$8.9652-Week Low$6.23

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.91
    SMA 20$8.29
    SMA 50$8.06
    SMA 200$7.86
    EMA 10$7.93
    EMA 20$8.08
    EMA 50$8.02
    EMA 200$7.68

    MACD

    Line: -0.13Signal: -0.03Hist: -0.09

    ADX

    ADX: 20.0+DI: 23.0-DI: 30.4

    Aroon & PSAR

    Aroon Up28.0
    Aroon Down96.0
    PSAR$8.23

    Bollinger Bands

    Upper Band$9.18
    Lower Band$7.41
    %B Position2130%(Upper)
    Band Width0.24

    RSI (14-Day)

    Neutral
    44.1

    Momentum Oscillators

    Stoch %K15.4
    Stoch %D14.4
    Williams %R-71.9
    ROC (10d)-4.5%
    Momentum-0.37
    CCI (20d)-87.6
    MFI (14d)32.4

    Volatility Measures

    ATR (14d)$0.27(3.4%)
    StdDev (20d)0.44
    Hist Vol34.7%(Moderate)

    Volume Flow

    VWAP$7.78
    OBV892.2K
    AD Line-48.7M
    CMF (20d)0.042

    Volume Metrics

    Avg Vol (20d)96.7K
    Vol Ratio0.6x
    VWMA (20d)$8.38

    Pivot Points

    R3$7.89
    R2$7.77
    R1$7.69
    Pivot Point$7.57
    S1$7.49
    S2$7.37
    S3$7.29

    Advanced Oscillators

    TSI-10.47
    Ultimate Osc48.9
    KST-26.90

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$54.92M$45.24M$44.68M$47.01M$44.75M$44.02M$39.01M$41.74M$42.47M$37.74M$36.43M$37.93M
    Cost of Revenue$32.45M$26.12M$27.71M$27.25M$25.82M$23.27M$21.97M$24.51M$23.52M$20.98M$22.02M$23.13M
    Gross Profit$22.47M$19.12M$16.97M$19.76M$18.93M$20.75M$17.03M$17.23M$18.95M$16.75M$14.41M$14.80M
    Operating Expenses$12.96M$12.16M$13.42M$11.95M$11.86M$12.95M$11.95M$11.94M$13.31M$12.71M$11.64M$10.44M
    R&D$2.20M$2.18M$2.89M$2.64M$3.22M$4.25M$2.67M$3.41M$4.80M$4.29M$3.24M$3.18M
    SG&A$5.82M$5.23M$11.03M$4.82M$4.07M$4.20M$8.83M$4.01M$3.78M$3.79M$7.65M$3.70M
    Operating Income$9.51M$6.95M$3.55M$7.82M$7.07M$7.79M$5.08M$5.29M$5.64M$4.04M$2.78M$4.37M
    Interest Income$434,000$425,000$442,000$492,000$453,000$534,000$684,000$646,000$508,000$280,000$496,000$67,000
    Interest Expense$368,872$188,000$259,000$221,000$192,000$192,000$189,000$167,000$145,000$159,000$159,000$404,000
    Income Before Tax$10.19M$5.39M$4.73M$6.37M$5.75M$6.61M$2.46M$3.95M$4.49M$2.44M$5.02M$3.30M
    Income Tax Expense$927,000$1.26M$1.17M$1.07M$-1,623,000$2.65M$-1,349,000$84,000$63,000$74,000$-34,000$73,000
    Net Income$9.26M$4.13M$3.56M$5.30M$7.38M$3.96M$3.81M$3.86M$4.43M$2.37M$5.06M$3.22M
    EBITDA$13.40M$9.43M$8.79M$10.35M$9.69M$10.42M$6.75M$7.36M$7.86M$5.83M$8.19M$6.88M
    EBIT$9.51M$5.58M$4.99M$6.59M$5.95M$6.80M$2.65M$4.11M$4.63M$2.60M$4.98M$3.70M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about KMDA

    KMDA Valuation and Fair Value

    P/E
    20.6x
    Forward P/E
    16.5x
    P/FCF
    17.1x
    PEG
    0.7x
    P/B
    1.7x
    See GNG's fair value

    KMDA Profitability: Margins, ROIC and FCF

    Gross margin
    40.8%
    Operating margin
    17.3%
    Net margin
    11.6%
    ROE
    8.4%
    FCF margin
    13.8%
    FCF yield
    5.8%

    KMDA Competitors

    CompanyTicker
    Neurogene IncNGNE
    Oculis Holding AG Ordinary sharesOCS
    Cerus CorporationCERS
    Alpha Teknova IncTKNO
    National Research CorpNRC
    XOMA CorporationXOMAO
    Brainsway LtdBWAY
    XOMA Royalty CorporationXOMAP

    Sector: Healthcare

    KMDA Analyst Ratings

    Consensus
    Buy
    Analysts
    3
    Strong Buy
    0
    Buy
    3
    Hold
    0
    Sell
    0
    Strong Sell
    0

    KMDA Bull Case vs Bear Case

    Bull case

    • KMDA grew quarterly revenue 22.7% year over year.

    Bear case

    • KMDA beat EPS estimates in 37.5% of its last 8 reported quarters.

    KMDA Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    3.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.13
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 1 down

    KMDA Dividend

    Forward yield
    2.2%
    Payout ratio
    67.5%
    Pay months
    Apr, Sep

    Frequently Asked Questions About KMDA

    What is KMDA's current dividend yield?

    Kamada (KMDA) has a forward dividend yield of 2.17%.

    Does KMDA pay dividends?

    Yes, Kamada pays dividends with a forward dividend yield of 2.17%.

    What is KMDA's P/E ratio?

    Kamada has a price-to-earnings (P/E) ratio of 20.61.

    What is KMDA's market cap?

    Kamada (KMDA) has a market capitalization of $443.79M with a current stock price of $7.83.

    Related stocks

    Sector: Healthcare

    All stocks starting with K

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In